|
業務類別
|
Biotechnology |
|
業務概覽
|
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies. |
| 公司地址
| One Main Street, Suite 1350, Cambridge, MA, USA, 02142 |
| 電話號碼
| +1 617 410-4650 |
| 傳真號碼
| -- |
| 公司網頁
| https://cullinantherapeutics.com |
| 員工數量
| 111 |
| Dr. Jeffrey Alan Jones, M.D. |
Chief Medical Officer |
美元 511.89K |
25/04/2025 |
| Dr. Corinne Savill, PhD |
Chief Business Officer |
-- |
25/04/2025 |
| Dr. Jennifer Michaelson, PhD |
Chief Scientific Officer |
-- |
25/04/2025 |
| Mr. Nadim Ahmed |
Director, President and Chief Executive Officer |
美元 674.86K |
10/03/2026 |
| Ms. Mary Kay Fenton |
Chief Financial Officer and Principal Accounting Officer |
美元 333.81K |
10/03/2026 |
| Ms. Jacquelyn L. Sumer |
Chief Legal Officer, Chief Compliance Officer and Secretary |
-- |
25/04/2025 |
|
|
| Mr. Nadim Ahmed |
Director, President and Chief Executive Officer |
10/03/2026 |
| Mr. Stephen W. Webster |
Independent Director |
10/03/2026 |
| Mr. Anthony Rosenberg |
Chairman of the Board |
10/03/2026 |
| Dr. Andrew R. Allen, M.D.,PhD |
Director |
10/03/2026 |
| Ms. Mary T. Thistle |
Independent Director |
10/03/2026 |
| Mr. David D. Meek |
Independent Director |
10/03/2026 |
| Dr. Mittie Doyle, F.A.C.R.,M.D. |
Director |
10/03/2026 |
|
|
|
|
